BG Medicine Announces Decision by American Medical Association and Centers for Medicare and Medicaid Services on Analyte-Specific CPT(R) Code and Reimbursement for BGM Galectin-3(R) Test

[at noodls] – WALTHAM, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that the … more

View todays social media effects on BGMD

View the latest stocks trending across Twitter. Click to view dashboard